Literature DB >> 3064106

Inflammatory mediators and asthma.

P J Barnes1, K F Chung, C P Page.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3064106

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  80 in total

Review 1.  Review of psychosocial stress and asthma: an integrated biopsychosocial approach.

Authors:  R J Wright; M Rodriguez; S Cohen
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4.

Authors:  S E Sampson; A P Sampson; J F Costello
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

3.  The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation.

Authors:  F Lembeck; J Donnerer; M Tsuchiya; A Nagahisa
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 4.  Bradykinin and asthma.

Authors:  P J Barnes
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

Review 5.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  Modulation of bradykinin responses in airway smooth muscle by epithelial enzymes.

Authors:  N Frossard; C D Stretton; P J Barnes
Journal:  Agents Actions       Date:  1990-11

7.  The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation.

Authors:  K H Banner; E Moriggi; B Da Ros; G Schioppacassi; C Semeraro; C P Page
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

8.  Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model.

Authors:  Long P Nguyen; Rui Lin; Sergio Parra; Ozozoma Omoluabi; Nicola A Hanania; Michael J Tuvim; Brian J Knoll; Burton F Dickey; Richard A Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

9.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; D A Burroughs; M Yeadon; C P Page
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

10.  Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.

Authors:  J E Souness; C Maslen; S Webber; M Foster; D Raeburn; M N Palfreyman; M J Ashton; J A Karlsson
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.